<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0007108"><a href="http://purl.obolibrary.org/obo/MONDO_0007108">MONDO:0007108</a></h3>
<p><strong>Label:</strong> anal canal carcinoma</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0002735">MONDO:0002735</a> (anal canal adenocarcinoma (disease)),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_424016">Orphanet:424016</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) and <a href="http://purl.obolibrary.org/obo/HP_0100834">HP:0100834</a> (Neoplasm of the large intestine) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) and <a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) and <a href="http://purl.obolibrary.org/obo/HP_0100606">HP:0100606</a> (Neoplasm of the respiratory system) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) and <a href="http://purl.obolibrary.org/obo/HP_0100526">HP:0100526</a> (Neoplasm of the lung) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) and <a href="http://purl.obolibrary.org/obo/HP_0030437">HP:0030437</a> (Anal canal neoplasm) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) and <a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010622">HP:0010622</a> (Neoplasm of the skeletal system) and <a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0007378">HP:0007378</a> (Neoplasm of the gastrointestinal tract) and <a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006749">HP:0006749</a> (Malignant gastrointestinal tract tumors) and <a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002896">HP:0002896</a> (Neoplasm of the liver) and <a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002733">HP:0002733</a> (Abnormality of the lymph nodes) and <a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002716">HP:0002716</a> (Lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) and <a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0012432">HP:0012432</a> (Chronic fatigue) 100.00%</li>
</ul>
</body>
</html>
